Investor Presentaiton
INVESTMENT HIGHLIGHTS
שיי
High quality assets in
high-growth markets
Blue-chip pedigree
management team
Significant embedded
growth potential
Demonstrated ability to
consolidate
Organizational emphasis
on R&D and innovation
Organizational emphasis on R&D and innovation
CUTTING EDGE PRODUCT DEVELOPMENT
Highly decorated team developing unique product
offerings with expected mass market potential,
MICROBIALLY PRODUCED CANNABINOIDS
Exclusive technology partnership with Intrexon enables
low-cost production of rare cannabinoids:
highlighted by a patent-pending nanoemulsion.
beverage:
8-minute onset time
Enhanced flavoring profile
Micro-dosage
0
שיי
BIOSCIENCES
UPMC
LIFE CHANGING MEDICINE
New drug discovery platform
Unique product offerings
(i.e. THC-V, CBG)
Supply and cost advantages over
competitors who operate traditional
cultivation and production platforms
PARALLEL BIOSCIENCES
Parallel's internal R&D arm, leads all internal research
and product development (i.e. proprietary form factors
such as CBN drops)
RESEARCH PARTNERSHIPS
Parallel is an important player in cannabinoid research,
partnering with renowned domestic and international research
institutions like University of Pittsburgh Medical Center to
address biological research and drug discovery
25View entire presentation